Anti-PD-L1 Therapy as a Solution for Non-Melanoma Skin Cancer Basal Cell Carcinoma

Rahul Simon Situmeang, Gim Mi Kyong, Rosiva Betaria Purba , Wahyu Irawati

Abstract

Skin cancer is a disease that can cause the loss of the ability to regenerate and protect the skin normally.  The types of skin cancer that are known are melanoma and non-melanoma skin cancer.  Non-melanoma Basal cell carcinoma is a malignant neoplasm originating from non-keratinizing cells in the basal layer of the skin's epidermis.  The treatment itself is carried out through the application of immunotherapy, namely the use of drug therapy Programmed Death Ligand 1 (PD-L1).  This study aims to see the effectiveness of PD-L1 Therapy as a treatment for basal cell carcinoma.  The focus of the study of the article is the integument system, skin cancer, non-melanoma basal cell carcinoma, and the effect of anti-PD-L1 use.  The research method used is a literature review from various sources.  Skin cancer Basal cell carcinoma attacks the basal cells of the epidermis, causing disruption.  Attacks slowly, but when ignored will spread wider and more severe.  Through PD-L1 therapy by binding to PD-1 receptors on immune cells, it causes the activation of T lymphocytes as anti-cancer cells in the body that suppress growth while actively controlling tumor cells.  Through the use of PD-L1 therapy in treating cancer that attacks basal cells, it will suppress growth, destroy and shrink cancer cells, and increase the body's immunity against cancer cells.  

Full text article

Generated from XML file

References

Braun, Scope, A., Marghoob, A., & Kerl, K. (2012). Histopathologic tissue correlation of demoscopic structures. Informa Health care, 10-32.
Dewi. (2017). Sebaran kanker di Indonesia, riset Kesehatan Dasar. Indonesian Journal of cancer, 1-8.
Fakhrosa, I., Sutedja, E. K., Agusni, J. H., Feriza, V., & Saraswati, N. A. (2018). Manifestasi Klinis dan Gambaran Dermoskopi pada Karsinoma Sel Basal. Syifa' MEDIKA, VIII, 54-67.
Fatmasari, & Djakaria, H. (2017). Radioterapi Pada Krsinoma Sel Basal. Radioterapi & Onkologi Indonesia , 93-97.
Fitriatuzzakiyyah, N., Sinuraya, R., & Puspitasari, I. (2017). Terapi Kanker dengan Radiasi: Konsep Dasar Radioterapi dan Perkembangannya di Indonesia. Jurnal Farmasi Klinik Indonesia, VI, 311-320. doi:10.15416/ijcp.2017.6.4.311
Hanriko, R., & Hayati, S. J. (2019). Non-Melanoma Skin Cancer (NMSC) pada Pekerja Luar Ruangan dan Intervensinya. J Agromedicine, Vol.VI, 405-409.
Ikeda, S., Goodman, A. M., Cohen, P. R., Jensen, T. J., Ellison, C. K., Frampton, G., . . . Kurzrock, R. (2016). Metastatic Basal Cell Carcinoma with Amplification pf PD-L1: Exceptional Response to Anti PD-L1 Therapy. Nature Partner Journals, 1-5.
Kalangi, S. J. (2013). Histofisiologi Kulit. Jurnal Biomedik Vol.V, 12-20.
Lawrenti, H. (2018). Perkembangan Immunoterapi Untuk kanker . Analisis: CDK-267, 616-621.
Lestari, S., Yenny, S. W., Akhyar, G., Kampar, P., PPAF, T., L, F., & Holmes. (2018). Eksisi Dengan Subcutaneus Bipedicle Island Flap Pada Karsinoma Sel Basal Tipe Nodulo Ulserasi Dengan Anestesi Umum dan Anestesi Lokal Timescent. MDVI, Vol.III, 142-145.
Lipson, E. J., Lilo, M. T., Ogurtsova, A., Esandrio, J., Xu, H., Brothers, P., . . . Taube, J. M. (2017). Basal Cell Carcinoma: PD-L1/PD-1 Checkpoint Expression and Tumor Regression after PD-1 Blockade. Journal for ImmunoTherapy of Cancer, 1-5.
Longo, C., Lallas, A., & Kyrgidis, A. (2014). Classifying distinct basal cell carsionoma subtype by eans or dermascopy and reflectance concofal microscopy. J Am Acad, 1-9.
Miryana, W., Reza, N. R., Sarwono, I., & Cholis, M. (2013). Gambaran Hispatologi Karsinoma Sel Basal. MDVI, Vol.III, 138-144.
Mohartono, & Hanriko, R. (2017). Sosialisasi Bahaya Kanker Kulit (Melanoma Maligna) dan Pemeriksaan Kesehatan Gratis Bagi Masyarakat di Kecamatan Kemiling Bandar Lampung. JPM Ruwa Jurai, 81-84.
Moraskar, A., Shirodkar, S., & Lambor, D. (2015). Pigmented basal cell carcicoma, a rare case report. J Oto Head Neck Surg, 121-124.
Novitasari, A., Ridlo, S., & Kristina, T. N. (2017). Instrumen Penilaian Diri Kompetensi Klinis Mahasiwa Kedokteran. Journal of Educational Research and Evaluation, 81-89.
Pramono, M., Saraswati, M., & Zuraidah, E. (2019). Efek Aktivasi Programmed Death Ligand 1 (PD-L1) pada Adenokarsinoma Paru. Pratista Patologi, 55-67.
Pramudianti, M. I., Sidharta, B. R., & Sinambela, J. (2017). Kadar Osteopontin dan 25-OH Vitamin D Pada Pasien Diabetes Melitus TIpe-2 Terkontrol dan Tak Terkontrol. MEDIKA, Vol.VI, 1-33.
Pramuningtyas, R., & Mawardi, P. (2012). Gejala Klinis Sebagai Prediktator Pada Karsinoma Sel Basal. Biomedia , 33-35.
Putri, D. D., Furqon, T., & Perdana, R. S. (2018). Klasifikasi Penyakit Kulit Pada Manusia Menggunakan Metode Binary Decision Tree Support Vector Machine (BDTSVM). Jurnal Pengembangan Teknologi Informasi dan Ilmu Komputer, II, 1912-1920.
Raflizar, & Nainggolan, O. (2010). Faktor Determinan Tumor/Kanker Kulit di Pulau Jawa (Analisis Data RIKDESDAS 2007). Buletin Penelitian Sistem Kesehatan, Vol. XIII, 386-393.
Sabbatino, F., Marra, A., Liguori, L., Scognamiglio, G., Fusciello, C., Botti, G., . . . Pepe, S. (2018). Resistance to Anti-PD-1-Based Immunotherapy in Basal Cell Carcinoma: a Case Refort and Review of the Literature. Journal for ImmunoTherapy of Cancer, 1-8.
Sagoyo, W., Widodo, A. D., & Dachlan, Y. P. (2017). Potensi +Dalethyne Terhadap Epitelisasi Luka Pada Kulit Tikus yang Diinfeksi Bakteri MRSA. Jurnal Biosains Pascasarjana Vo.XIX, 68-84.
Setiabudi, J., Wardhana, M., Indira, I. G., & Puspawati, N. M. (2021). Profil Pra Kanker dan Kanker Kulit di RSUP Sanglah Periode 2015-2018. Jurnal Medika Udayana, 83-88.
Setiawan, A. F., Wijono, & Sunaryo. (2013). Sistem Cerdas Penghitung Sel Kulit Mati Manusia dengan Metode Improved Counting Morphology. Jurnal EECCIS, Vol.VII, 28-34.
Sugiharto. (2006). Pendekatan Baru Terapi Kanker. MEDIKORA, Vol. II, 39-56.
Suryani, A. (2020). Faktor-Faktor yang Memengaruhi Pigmentasi Manusia. CDK-290, Vol.XLVII, 682-685.
Tan, S. T., Ghaznawie, M., & Reginata, G. (2016). Deteksi Dini Karsinoma Sel Basal. Indonesian Journal of Cancer, X, 61-66.
Wilvestra, S., Lestari, S., & Asri, E. (2018). Studi Restrospektif Kanker Kulit di Poliklinik Ilmu Kesehatan Kulit dan Kelamin RS Dr. M. Djamil Padang Periode Tahun 2015-2017. Jurnal Kesehatan Andalas, 47-49.
Book:
Hasliani. (2021). Sistem Integumen. Makassar: CV. Tohar Media.
Youseft, H., Alhajj, M., & Sharma, S. (2021). Anatomy, Skin (Integument), Epidermis. Treasure Island (FL): StatPearls Publishing.

Authors

Rahul Simon Situmeang
Gim Mi Kyong
Rosiva Betaria Purba
Wahyu Irawati
w.irawati3@gmail.com (Primary Contact)
Situmeang, R. S., Kyong, G. M., Purba , R. B., & Irawati, W. (2022). Anti-PD-L1 Therapy as a Solution for Non-Melanoma Skin Cancer Basal Cell Carcinoma . BIOEDUSCIENCE, 6(1), 48–56. https://doi.org/10.22236/j.bes/618095

Article Details

Most read articles by the same author(s)